Search
for
Sort by
Research 421–450 of 1000+
- From the Literature<i>J Investig Dermatol</i>, Symp Proc 1999 December; for (3); 2~2-4; Authors: Whiting DA et alREVIEW: Ahmet Seyhan, MD, Levent Yoleri, MD, Ali Barutcu, MD: Immediate hair transplantation into a newly closed wound to conceal the final scar on the hair-bearing skin. <i>Plast Reconstr Surg</i>, 105:5, 1866-1870, 2000.REVIEW: Handbook of Diseases of the Hair and Scalp. By Rodney Sinclair, Cedrick Banfield and Rodney Dawber; 233 Pages. Published by Blackwell Science 1999.
- Comparison of Microneedling with Platelet Rich Plasma vs Minoxidil (5%)+Finasteride (0.1%) Topical Therapy in Androgenetic Alopecia: A Randomised Clinical Study
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Long-Term (Over 10 Years) Evaluation of Efficacy and Safety of Finasteride in Japanese Men with Androgenetic Alopecia: Summary of Three Investigations
- Effects of antiandrogen therapy of cyproteron acetate on androgen effects on the skin including androgenetic alopecia in menopausal women – case report: 10 years follow up –
- Efficacy and safety of 10% topical minoxidil, oral finasteride and microneedling in Male Pattern Baldness
- Application of 2-Chloro-7-Nitrobenzo-2-Oxa-1, 3-Diazol (NBDCL) for Spectrophotometric Determination of Finasteride in Pharmaceutical Formulation
- Stress And Hair Loss in Miami .108
- Hormonal Control of Cardiac Action Potential Phase 1 Currents in the Brugada Syndrome
- 地域・国際レポート 「あいちトリエンナーレ2010」の実施とその成果検証(中間とりまとめ)について
- THERAPEUTIC HOTLINE Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up
- Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
- [Treatment of moderately severe virilism of women with Diane and Androcur 10].
- Clinical Study of Patients with Female Pattern Hair Loss Over a 10-year Period
- SF-066-4 線維芽細胞+血管内皮前駆細胞共培養シートを用いた新たな膵断端処理法の開発(膵-2,サージカルフォーラム,第110回日本外科学会定期学術集会)
- Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics
- Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia
- Tissue engineering of human hair follicles using a biomimetic developmental approach
- Mechanical stretch induces hair regeneration through the alternative activation of macrophages
- Genomewide Scan for Linkage Reveals Evidence of Several Susceptibility Loci for Alopecia Areata
- PDGF isoforms induce and maintain anagen phase of murine hair follicles
- Scarless wound healing: finding the right cells and signals
- Evidence for Novel Functions of the Keratin Tail Emerging from a Mutation Causing Ichthyosis Hystrix
- Probiotic Bacteria Induce a ‘Glow of Health’
- Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Oral retinoids-present status
- Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis
- A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity
- Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata